AGCO

Phase A — Understand the business

Lens 1 · Company Overview

AGCO is the world's third-largest pure-play agricultural-machinery maker, behind Deere and CNH Industrial — its own 10-K names those two as "our two principal competitors on a worldwide basis". It designs, manufactures and sells tractors, combines, sprayers, hay/forage tools, implements, replacement parts, and a growing precision-ag stack, distributed through ~2,800 independent dealers and distributors in ~140 countries.

The business runs on four "differentiated leading brands": Fendt™ (premium high-horsepower, Europe-anchored, the crown jewel), Massey Ferguson™ (mass-market global), Valtra™ (Nordic/Latam), and PTx™ (the brand-agnostic precision-ag portfolio). AGCO Power, an in-house division, builds 75–500 hp off-road diesel engines for a majority of AGCO's own machines and sells to third parties.

Revenue model: AGCO sells to dealers, not farmers; dealers carry inventory on floor-plan financing provided primarily through the AGCO Finance joint ventures (AGCO 49% / Rabobank 51% — Rabobank controls and funds them). The JVs finance ~50% of retail tractor/combine sales in their markets. Key payment-term feature: in the US/Canada, dealers get interest-free periods of 1–12 months (occasionally to 24), and the receivable is immediately due on the dealer's retail sale — a structure that makes AGCO's reported sales sensitive to dealer order/destock behaviour, not just farmer demand.

FY2025 scale: net sales $10,082.0M (down 13.5% YoY), 22,000 employees. Tractors and combines are ~68.8% of sales.

Lens 2 · Supply Chain

Upstream inputs → AGCO → end farmer, named stakeholders along the chain:

• Raw inputs: steel and aluminum (explicitly tariff-exposed — the 10-K flags US tariffs on imported steel/aluminum raising COGS); semiconductors (the 10-K notes prior supply-chain disruptions "for several key components, such as semiconductors").
• In-house engines: AGCO Power (diesel engines/gears/gensets) — vertical integration into the powertrain, a structural cost/control advantage versus buying engines.
• Third-party whole-machine/component suppliers (named): SDF S.p.A., Carraro S.p.A., Iseki & Company, and — historically — TAFE (Tractors and Farm Equipment Limited). AGCO terminated all commercial relationships with TAFE in April 2024; TAFE purchases fell from $165.9M (2024) to $55.2M (2025) and are expected to go to immaterial.
• Manufacturing footprint: significant plants in France, Germany, Brazil, Italy, Finland, plus China; Fendt is centred in Germany. A majority of sales and manufacturing is outside the US — the largest sales countries are Germany, France, Brazil, UK, Australia, Italy, Finland, Canada. This is the natural hedge management leans on against US tariffs ("partially mitigated as a majority of our sales and manufacturing takes place outside the United States").
• Distribution chokepoint: the ~2,800 independent dealer network is both moat and single point of friction — dealer-protection laws in many jurisdictions "could adversely affect our ability to terminate our dealers".
• Financing chokepoint: Rabobank. The retail/wholesale credit that funds ~50% of sales runs through Rabobank-controlled JVs; the 10-K is explicit that a Rabobank pullback would force AGCO to "find other sources of financing (which may be difficult to obtain)". (See Lens 5/9 — AGCO is now buying its way out of this dependency region by region.)

Single-source/chokepoint summary: steel/aluminum (tariffed), semiconductors (historically scarce), and Rabobank financing are the three real chokepoints. PTx Trimble adds a software/positioning-tech supply layer (GNSS correction, guidance) partly sourced from the Trimble side of the JV.

Lens 3 · Competitive Advantages (moats)

The moat is real but narrow and regional.

1. Fendt brand premium (the durable edge). Fendt is a genuine premium franchise in European high-horsepower — pricing power, brand loyalty, and a halo that AGCO is exporting globally ("continuing global expansion of Fendt", 5 new machines + 17 innovations in 2025). This is where AGCO's economics actually work (see Lens 4 — EME is ~169% of total operating income).
2. Mixed-fleet / brand-agnostic precision ag (the growth moat, unproven). PTx + PTx Trimble is positioned to sell retrofit + factory-fit precision tech that works on any brand's machines — a different wedge than Deere's closed John Deere Operations Center. Target: $2B PTx revenue by 2029 (from ~$850M), mid-cycle EBIT 14–15% vs 7–7.5% today. If it works it's a higher-margin, stickier software layer; if it doesn't it's a $2.0B acquisition that already ate a $350M impairment.
3. Scale + in-house engines (AGCO Power) — real but structurally subscale versus Deere/CNH, which the 10-K concedes are "substantially larger… and have greater financial and other resources".
4. Distribution density — the 2,800-dealer network and FarmerCore on-farm model (two-thirds of NA dealers now >50% on-farm capacity).

Bargaining power: weak-to-moderate. Against farmers/dealers AGCO has Fendt pricing power but limited mass-market pricing power (worldwide price +1.1% in 2025, +1.6% in Q1-2026 — thin). Against suppliers it is the smallest of the big three, and it is dependent on Rabobank for the financing rail. Net: a quality #3 with one world-class brand, not a Deere-class moat.

Lens 4 · Segments

AGCO reports four geography-based segments (no product-line P&L). Effective Jan 1, 2026 it renamed South America → LATAM and moved Mexico out of North America into LATAM.

FY2025 by region:

*Total-company sales −13.5% incl. the divested G&P "Other" bucket ($816.5M in 2024).

The single most important fact about AGCO: EME's $1,006.8M operating income is ~169% of the entire company's $595.7M consolidated operating income. North America lost $112.0M; South America and APA together made ~$79M; corporate/eliminations absorb the rest. AGCO is a European tractor company with loss-making/marginal appendages elsewhere.

Q1-2026 by region confirms and sharpens this:

EME's Q1 operating income ($259.0M) is 3.2x the whole company's $80.7M. North America's loss deepened to $(51.0)M despite sales rising $36.9M — management is explicit it's "higher tariff-related input costs". LATAM swung to a $(40.9)M loss on Brazil weakness + negative pricing. Trend: EME accelerating (op income +68% YoY in Q1), North America deteriorating on tariffs, LATAM rolling over. The recovery is entirely Europe-led.

Phase B — Measure performance

Lens 5 · Earnings Result (latest print: Q1-2026, reported 2026-05-05)

The print: net sales $2,342.9M, +14.3% YoY (from $2,050.5M); income from operations $80.7M, +63% (from $49.4M); GAAP diluted EPS $0.76 (from $0.14); adjusted EPS $0.94 (from ~$0.41). Tractor/combine units +20.3%, production hours +14.9% — a real volume inflection, the first clean growth quarter after the FY2025 trough.

Beat/miss: beat — "exceeded analyst expectations"; stock +5.1% on the print + guidance raise + buyback.

Drivers: higher volumes in EME, NA and APA (most in high-horsepower tractors) + FX. Gross margin fell slightly (24.8% vs 25.4%) "primarily due to higher manufacturing costs, including increased tariff-related input costs" — operating leverage came from SG&A/volume, not gross margin.

Guidance (raised/tightened with the print): FY2026 net sales $10.5–10.7B, adjusted EPS ~$6, adjusted operating margin 7.5–8.0%, FCF conversion 75–100% of adjusted net income. Tone: constructively cautious — "modestly increase" sales on flat industry.

Balance-sheet flags: Q1 is a seasonal working-capital sink — inventories built −$284.1M and receivables −$177.1M in the quarter; this is normal (working capital "typically increase[s] in the first half") but worth tracking that inventories don't outrun the recovery. Debt-to-capitalization 36.6% (vs 35.8% at YE2025); $1.25B revolver with only $115M drawn ($1,135M available); notes laddered 5.450% '27 / 0.800% '28 / 5.800% '34 + EIB term loans '29/'30.

FY2025 context (the trough year): net sales $10,082.0M (−13.5%); gross margin 25.5% (up from 24.9% on lower mfg cost); income from operations $595.7M (5.9%); GAAP net income $726.5M / $9.75 diluted. Caveat — GAAP EPS is badly flattered: it includes a $251.9M gain on the TAFE stake sale (in Other income) and a net tax benefit (~$179.8M federal + ~$82M) from a legal-entity reorganization. Strip those and the underlying earnings power is the $595.7M operating line, not $726.5M. Operating cash flow $988.1M, capex $247.9M → FCF ≈ $740M.

Lens 6 · Earnings Calls (sentiment trend)

No transcripts in the research layer (transcripts=0); sentiment reconstructed from web call coverage, labeled ``.

• Q4-2024 / early 2025 (trough + TAFE attack): defensive. Activist TAFE publicly branded results "disappointing" and the PTx Trimble integration "botched" (Feb 11, 2025). Management messaging = "2025 is the industry trough," cost discipline, restructuring.
• Q4-2025 (Feb 2026): turning constructive — "record global market share and Net Promoter Score," Fendt expansion, TAFE overhang resolved.
• Q1-2026 (May 2026): confident but hedged — "balances growth with tariff risks" is the recurring frame across coverage. Raised guide + started buyback + raised dividend = management putting money behind the recovery call.

Phrases that recur: "Farmer-First," "high-horsepower," "precision ag / PTx," "structural cost reduction," "trough/recovery." Phrases that disappeared: special/variable dividends (gone — see Lens 9), and the defensive TAFE-litigation language (resolved). Net tone shift: from defensive-trough (early 2025) → cautious-recovery with a tariff asterisk (mid-2026).

Lens 7 · Comps

Peers from _index.json (topic=agtech): Deere (DE), CNH Industrial (CNH), Corteva (CTVA — inputs, not equipment, excluded), Benson Hill (private, excluded). Add Kubota (foreign) for context.

Read: AGCO is the cheapest of the big three on EV/EBITDA (~10.2x) and TTM P/E (~11.4x) — a clear discount to CNH (~14.5x EV/EBITDA) and a deep discount to Deere's premium. The discount is earned: smaller, EME-dependent, lower mid-cycle margin, North America losing money, PTx unproven. But on a forward basis (~22x on the trough-recovery ~$6 adj EPS) it's not statistically cheap — the cheapness is on trailing/EV-EBITDA, i.e. a bet on through-cycle normalization, not a low forward multiple. Note: the high-30s sector EV/EBITDA reflects depressed trough EBITDA, not euphoria. Exact Deere/Kubota multiples not sourced this run → n/a.

Lens 8 · Stock-Price Catalysts (>5% moves, ~5yr)

• Apr 28, 2021 — all-time high $158.62. The stock has de-rated since; at ~$133 (Feb 2026) it's still below the 2021 peak five years later.
• May 2022 — Black Basta ransomware attack halted operations; multi-quarter business-interruption insurance recoveries booked into 2024.
• 2022–2023 — special/variable dividends ($4.50 in 2022, $5.00 in 2023) as the up-cycle peaked (EPS peaked $15.63 in 2023).
• 2024 — restructuring announced (Jun 24, 2024), G&P divestiture (Nov 1, 2024, $507.3M loss-on-sale), PTx Trimble closed ($2.0B / 85%) — portfolio reshaped.
• Feb 11, 2025 — TAFE goes public/activist, branding results "disappointing" and PTx integration "botched" — a clear overhang on the stock through H1-2025.
• Jan 24, 2025 — Deere patent case won (Precision Planting; Deere did not seek cert → final) — removed a litigation tail.
• Jul 1, 2025 — TAFE settlement ($260M stake buyback, Massey Ferguson India to TAFE, standstill) — overhang cleared.
• May 5, 2026 — Q1 beat + guide raise + $350M buyback + dividend to $0.30 → +5.1%.

Pattern: the market reacts to (1) the ag cycle (farm income / dealer orders — the dominant driver), (2) capital-return signals (special dividends up-cycle, buybacks now), and (3) idiosyncratic overhangs (TAFE activism, the cyber attack, PTx impairment headlines). It is not a daily-newsflow trader's stock — it trades the cycle and the self-help.

Phase C — Judge people & books

Lens 9 · Management

CEO: Eric Hansotia — Chairman, President & CEO (also held COO before the top job; long-tenured AGCO operator).

1. Track record: Steered AGCO through the up-cycle to a 2023 EPS peak of $15.63, then orchestrated a hard portfolio reshape into the downturn — exited Grain & Protein (Nov 2024), bought 85% of Trimble Ag for $2.0B to build PTx, and resolved the TAFE conflict. Record market share and NPS claimed in 2025. Mixed: the PTx Trimble deal already required a $350M impairment and drew explicit activist criticism.
2. Tenure & skin in the game: long AGCO tenure, but thin ownership — ~0.27% of shares (~326K shares, ~$22M). Professional manager economics, not a founder's stake.
3. Capital allocation: This is the live story and it's improving. AGCO has pivoted from up-cycle special/variable dividends ($5.00 '23, $2.50 '24) to systematic buybacks — $1.0B authorization (Jul 2025), $250M ASR (Nov 2025), $785M remaining, $350M more in Q2-2026, and the regular dividend raised to $0.30. Crucially, it is funding buybacks by monetizing the Rabobank finance JVs — selling the US + Canada AGCO Finance stakes for $190M (Apr 30, 2026), with more JV sales "to be evaluated". That's a deliberate de-capitalization of the balance sheet to return cash — shareholder-friendly, but it also unwinds a structural relationship and a stream of JV equity earnings ($40M/yr).
4. Red flags: CEO comp $19.66M in 2025, +25.1% YoY — a sizeable raise in a year sales fell 13.5% and North America lost money. Optically poor against the cycle. TAFE (16.3% holder) publicly questioning management credibility was a governance flag, now muted by the standstill. Board strengthened with James C. Collins Jr. (ex-Corteva CEO).
5. Archetype: professional manager/operator running a cyclical reshaping playbook — disciplined on cost and portfolio, aggressive on capital return, but lightly invested personally. Fine for this stage (cycle management) — less of an owner-operator conviction signal than a founder-led peer.

Lens 10 · Forensic Red Flags

Acting forensically across the statements:

• GAAP earnings quality — the biggest flag. FY2025 GAAP net income $726.5M is inflated by ~$432M of one-offs: the $251.9M TAFE gain (Other income) and a net tax benefit ~$179.8M+$82M from legal-entity reorg. The honest earnings power is the $595.7M operating line / 5.9% margin, and even that benefited from "lower manufacturing costs." Anyone anchoring on $9.75 GAAP EPS or a ~11x P/E on it is mis-reading the run-rate. (Adjusted EPS ~$6 guide for 2026 is the cleaner anchor.)
• Off-balance-sheet receivables. AGCO sells the majority of its wholesale receivables to the Rabobank JVs and factors trade receivables to third parties "as off-balance sheet transactions"; losses on sales of receivables were $90.3M in 2025 (and $18.6M in Q1-26) sitting in Other expense. This flatters reported receivables/working capital and pushes a financing cost below the operating line — standard for the industry, but it means the balance sheet understates true credit exposure to the dealer channel.
• Finance-JV equity method. ~$40M/yr of "equity in net earnings of affiliates" (mostly AGCO Finance) is real cash-light income that will shrink as JVs are sold — a quality-of-earnings headwind into 2027.
• Redeemable NCI / contingent cash call. PTx Trimble's redeemable noncontrolling interest (Trimble's 15%) is $295.5M and "may require the use of cash… beginning in 2027" — an embedded put / future cash drain not in headline debt.
• Goodwill/intangibles after PTx. A $369.5M goodwill impairment in 2024 (PTx Trimble NA) + a further $350M PTx impairment already taken show the $2.0B acquisition's carrying value is sensitive; watch for further write-downs if the $2B-by-2029 plan slips.
• Inventory vs revenue (Q1): inventories built $284.1M in Q1 — seasonal, but if the NA/LATAM recovery disappoints, this is where channel stuffing or markdowns would first show. Not a flag yet; a watch item.
• FX/Turkey hyperinflation accounting (Turkish lira) noted in Q1 — immaterial but present.

Regulatory findings (required sub-section):

• SEC enforcement: None. regulatory/regulatory-findings.md (fetched 2026-06-18 via SEC EDGAR EFTS) returns 0 Litigation Releases and 0 AAERs naming AGCO over 2021-06-18→2026-06-18.
• 10-K Item 3 (Legal Proceedings): the only matter disclosed is the Deere/Precision Planting patent suit (2018) — tried to a jury (July 2022) that found no infringement; affirmed by the Federal Circuit Jan 24, 2025; Deere did not seek cert → judgment final in AGCO's favor. AGCO states no other claims are individually or in aggregate material.
• Non-SEC enforcement (web search): no material FTC/DOJ/FDA/CFPB enforcement actions, consent decrees, or fines surfaced. The TAFE dispute was civil/commercial (arbitration + India litigation), now settled (Jul 2025) — not a regulatory action. The 2022 Black Basta ransomware event was a security incident, not an enforcement matter.
• Verdict: No material regulatory or accounting-enforcement findings — verified via SEC EDGAR EFTS (LR, AAER), web search, and 10-K Item 3 as of 2026-06-18. The genuine forensic risk is earnings-quality optics (one-off-inflated GAAP) and off-balance-sheet receivable financing, not fraud.

Phase D — Project & stress-test

Lens 11 · Forward Projection (FY2026 / FY2027 / FY2028 adjusted EPS)

Built bottom-up from the latest actuals + guidance; output ``, anchored on management's own FY2026 frame.

FY2026 (base): Management guides net sales $10.5–10.7B, adjusted EPS ~$6, adj op margin 7.5–8.0%. The Q1 inflection (units +20.3%, EME op income +68%) supports the top line; the ~$135M tariff cost (+$90M YoY, no IEEPA refund assumed) is the principal margin drag, concentrated in North America. Base FY2026 adj EPS ≈ $6.0.

FY2027 (base): ag cycle inflects up off the 2026 bottom (Deere/CNH both call 2026 the trough; CNH says recovery 2027); assume +6–8% sales (~$11.3–11.5B) on NA destock completion + continued EME strength + PTx ramp, adj op margin recovering toward ~9% as volume leverage returns and (if no refund) tariffs annualize. Offsets: shrinking finance-JV equity income, the PTx redeemable-NCI cash call from 2027. Base FY2027 adj EPS ≈ $7.25.

FY2028 (base): mid-cycle normalization toward AGCO's ~10%+ adj op-margin target as PTx mix and high-horsepower share build; Base FY2028 adj EPS ≈ $8.50.

At ~$133, base FY2026 ~$6 = ~22x, FY2027 ~$7.25 = ~18x, FY2028 ~$8.5 = ~15.6x. The multiple only looks reasonable if you believe the cycle turns and PTx margins inflect — i.e. you're paying ~22x trough-ish earnings for a normalization you can't yet see in North America.

(Breadth/watchlist loop — per SKILL, no forecast.ts create logged this pass. If promoted to a tracked call, the natural Brier line is "AGCO FY2026 adjusted EPS ≥ $6.00," p≈0.55, resolves 2027-02.)

Lens 12 · Bull vs Bear

Bull case. AGCO is a quality cyclical caught at the trough with self-help layered on top. Three legs: (1) Cycle — 2025/2026 is the bottom of a brutal ag-equipment downcycle (EPS $15.63 peak '23 → trough); Q1-2026's +14% sales and +20% unit growth say the inflection has begun, and history says ag-equipment earnings are violently mean-reverting. (2) Europe is a cash machine — Fendt + EME throw off ~$1B operating income at 15% margins through the cycle, funding everything else. (3) Self-help — PTx Trimble to $2B/14-15% EBIT by 2029, $200M cost-out, FarmerCore, and a shareholder-friendly capital-return pivot ($785M+$350M buybacks, dividend raised) funded by monetizing low-return finance JVs. Re-rate toward CNH/Deere multiples on a clean recovery year and you have a stock that compounds off a ~10x EV/EBITDA trough base. Contrarian view the market refuses to see: the EME profit engine is so dominant that AGCO is closer to a "European premium-tractor pure-play with optionality" than a struggling US ag-cyclical — and it's priced as the latter.

Bear case (permanent-impairment risks). (1) North America is structurally, not cyclically, broken right now — it lost money in FY2025 and lost more in Q1-2026 despite rising sales, purely on tariffs; if the ~$135M tariff drag is permanent and AGCO never gets Deere's IEEPA refund, NA is a multi-year earnings sink, not a recovery lever. (2) PTx Trimble is a $2.0B bet that's already impaired $350M+ and drew an activist "botched integration" call; missing the $2B-by-2029 / 14-15% margin path forces more write-downs and breaks the entire growth narrative. (3) The recovery may not come on schedule — CNH explicitly says "wait until 2027," Deere sees NA large-ag down 15-20% in FY2026; dealer orders are down 12-15%. Pre-mortem (18 months out, thesis broke): the 2026 "recovery" was a Europe-only, FX-aided head-fake; North America and Brazil stayed in the red on persistent tariffs + weak crop prices; PTx took another impairment; the finance-JV sales removed ~$40M of earnings just as the cycle disappointed; adj EPS came in ~$5 not $6, the ~22x forward multiple compressed, and the stock round-tripped to the low $100s. Are multiples too high? On forward earnings (~22x FY26), yes — the cheapness is trailing/EV-EBITDA only; you're paying up for a normalization that's visible in Europe but invisible in North America.

Lens 13 · Devil's Advocate (short-seller)

Dismantling the bull case:

• Revenue concentration is the kill shot. ~67% of sales and >100% of operating income come from EME. The entire company is European high-horsepower (Fendt). Anything that dents European farm income — CAP subsidy changes (the 10-K flags EU subsidy risk explicitly), a strong euro reversing the FX tailwind, a European crop-price shock — hits the only profitable leg. The "diversified global #3" framing is a fiction; this is a one-region earnings stream cross-subsidizing loss-makers.
• The moat is weaker than bulls think outside Fendt. Mass-market Massey Ferguson has thin pricing power (worldwide price +1.1% in a recovery) and faces Deere/CNH (both bigger, better-capitalized) plus Kubota in compact and a wall of Indian/Chinese low-cost tractors. PTx's "brand-agnostic" wedge competes head-on with Deere's vastly larger installed base and closed ecosystem.
• Most dangerous competitor bulls underestimate: Deere. Deere got an IEEPA tariff refund; AGCO's guide assumes none. Deere out-spends AGCO on R&D/precision by multiples and can discount AGCO out of North American share. If Deere prices aggressively into the trough, AGCO's NA losses deepen.
• Worst capital-allocation tells: paying $2.0B for 85% of Trimble Ag and impairing $350M+ already; raising the CEO's pay 25% to ~$20M in a down/loss-in-NA year; and selling the finance JVs to fund buybacks — financial engineering that buys EPS optics while removing ~$40M of recurring equity income and unwinding the Rabobank relationship that funds half of sales.
• Assumptions that must hold for ~$133: (a) FY2026 adj EPS ≈ $6 and the cycle keeps recovering into 2027-28; (b) tariffs prove transitory or refunded; (c) PTx hits its 2029 margin target; (d) EME stays at ~15% margins. Break any one and the ~22x forward multiple is unsupported.
• −20-30% growth-disappointment scenario: if FY2027 sales come in 20-30% below the recovery path (CNH's "no recovery till 2027+" case), adj EPS stalls near ~$5, NA stays loss-making, and a ~$5 EPS at even a 16x trough multiple is ~$80 — ~40% downside from ~$133.
• Single permanent-impairment scenario (most plausible): a structural North American cost disadvantage from sticky tariffs + a sub-scale precision-ag platform that can't reach Deere-class margins → NA never earns its cost of capital and PTx is serially impaired. Plausibility: moderate. It doesn't kill the company (Europe carries it), but it caps the equity well below where the bull case prices it.

Lens 14 · Management Questions (ordered by information value)

1. North America lost money in FY2025 and lost more in Q1-2026 on tariffs — how much of the ~$135M 2026 tariff cost is structural vs. recoverable (IEEPA refund / pricing / resourcing), and at what point does NA earn its cost of capital again?
2. PTx Trimble: you've impaired $350M+ and target $2B revenue / 14-15% EBIT by 2029 from ~$850M / 7-7.5% today — what are the year-by-year revenue and margin milestones, and what's the trigger for another impairment?
3. You're selling the US/Canada AGCO Finance JVs for ~$190M to fund buybacks and "evaluating" the rest — what's the through-cycle earnings and dealer-financing impact of fully exiting the Rabobank JVs, and why is buying back stock at ~22x forward a better use than retaining that ~$40M/yr equity income?
4. EME generates >100% of operating income — what is the concrete plan (and timeline) to make North America and Latin America independently profitable rather than EME-subsidized?
5. CNH says recovery waits until 2027 and Deere sees NA large-ag down 15-20% in FY2026 — what specifically in your order book justifies AGCO guiding to a 2026 sales increase, and how much is FX vs. real volume?
6. Worldwide price was only +1.1% (2025) / +1.6% (Q1-26) in a "recovery" — where is your pricing power outside Fendt, and is Massey Ferguson structurally a price-taker?
7. The PTx Trimble redeemable NCI is $295.5M and may require cash from 2027 — how will that be funded, and does it compete with the buyback?
8. What is the through-cycle (mid-cycle) operating-margin target for the whole company, and what's the bridge from 5.9% (2025) to it?
9. How exposed is European farm income — your profit engine — to CAP subsidy reform and a stronger euro, and how do you hedge that concentration?
10. The Massey Ferguson India brand is now TAFE's; what's the long-term plan for AGCO's presence in India and South Asia, the world's largest tractor market by units?
11. AGCO Power (in-house engines) — is vertical integration still an advantage in an electrifying/alternative-fuel powertrain world, or a stranded-asset risk?
12. FarmerCore and the dealer model: what hard ROI (sales/cost) has the on-farm shift delivered, and how does dealer health look given 12-15% lower orders into 2026?
13. CEO pay rose 25% to ~$20M in a down year with NA losses — how does the comp committee reconcile that with pay-for-performance, and what share-ownership guidelines apply to the CEO (currently ~0.27%)?
14. With TAFE now a standstill 16.3% holder voting with the board, how do you think about the register, potential M&A interest, and AGCO's own appetite to be an acquirer vs. a consolidation target?
15. If the 2026 recovery stalls into a CNH-style 2027+ scenario, what's the downside protection — how far can cost-out and buybacks defend EPS before the dividend is at risk?